文献速递乳房整形与再造

自体脂肪移植不增加乳房再造后肿瘤复发风险

Autologous Fat Grafting Does Not Increase Risk of Oncologic Recurrence in the Reconstructed Breast.
PubMed 文献 · Ann Plast Surg · 2020-01-01

本研究为匹配病例对照研究,纳入2000至2017年428例乳房,比较接受与未接受自体脂肪移植的乳房再造患者肿瘤复发情况。结果显示两组复发率无显著差异,调整后风险模型亦无统计学意义,提示自体脂肪移植肿瘤学安全。

要点

  • 自体脂肪移植不增加乳房再造后肿瘤复发率(8.2% vs 9.0%)。
  • 无病生存期两组无统计学差异(log-rank P=0.96)。
  • 需更大样本更长随访验证长期安全性。

核心结论

  • 自体脂肪移植用于乳房再造肿瘤学安全,不增加肿瘤复发可能性。

研究设计与样本

  • 匹配病例对照研究,2000至2017年单机构数据,纳入乳房切除后乳房再造女性患者,按乳房水平分析。

主要发现

  • 428例乳房中116例(27.1%)接受自体脂肪移植,312例(72.9%)未接受。
  • 两组肿瘤复发率无差异(8.2% vs 9.0%,P<1.000)。
  • 未调整风险比1.03(95%CI 0.41-2.60,P<0.957),调整后模型亦无统计学显著增加。
  • 无病生存期无统计学差异(log-rank P=0.96)。

临床怎么用

  • 可告知患者自体脂肪移植作为乳房再造辅助手段不增加肿瘤复发风险。

局限性

  • 需更大规模研究(如荟萃分析)和更长随访进一步阐明长期安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Autologous fat grafting (AFG) is a popular and effective method of breast reconstruction after mastectomy; however, the oncological safety of AFG remains in question. The aim of this study was to determine whether AFG increases the risk of cancer recurrence in the reconstructed breast. METHODS: A matched, case-control study was conducted from 2000 to 2017 at the senior author's institution. Inclusion was limited to female patients who underwent mastectomy and breast reconstruction with or without AFG. Data were further subdivided at the breast level. χ analyses were used to test the association between AFG status and oncologic recurrence. A Cox proportional-hazards model was constructed to assess for possible differences in time to oncologic recurrence. The probability of recurrence was determined by Kaplan-Meier analyses and confirmed with log-rank testing. RESULTS: Overall, 428 breasts met study criteria. Of those, 116 breasts (27.1%) received AFG, whereas 312 (72.9%) did not. No differences in the rates of oncologic recurrence were found between the groups (8.2% vs 9.0%, P < 1.000). Unadjusted (hazard ratio = 1.03, confidence interval = 0.41-2.60, P < 0.957) and adjusted hazard models showed no statistically significant increase in time to oncologic recurrence when comparing AFG to non-AFG. In addition, no statistical differences in disease-free survival were found (P = 0.96 by log rank test). CONCLUSION: Autologous fat grafting for breast reconstruction is oncologically safe and does not increase the likelihood of oncologic recurrence. Larger studies (eg, meta analyses) with longer follow-up are needed to further elucidate the long-term safety of AFG as a reconstructive adjunct.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Vyas KS, DeCoster RC, Burns JC, et al. Autologous Fat Grafting Does Not Increase Risk of Oncologic Recurrence in the Reconstructed Breast. Ann Plast Surg. 2020. PMID: 32049757. doi:10.1097/SAP.0000000000002285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。